Now We Know What a Type 1 Cure Could Look Like
The Type 1 cure is no longer theoretical. Human data now points to a blueprint: working cells, immune evasion, and durable immune modulation.
The Type 1 cure is no longer theoretical. Human data now points to a blueprint: working cells, immune evasion, and durable immune modulation.
The diabetes pipeline is starting to look a lot like the cardiovascular playbook: prevent early, intervene earlier, and push treatment upstream before irreversible damage begins. […]
Whilst the title of this edition sounds like something out of science fiction, in it we see a masterclass in “biological intelligence.” As of February […]
The developments highlighted in the bolus today reinforce a theme Diabettech has been circling for years: the most meaningful progress in diabetes does not come […]
Recent news has been defined by a pivot toward “biological intelligence.” As of January 21, 2026, the signal cutting through the noise isn’t just about […]
For most of its history, type 1 diabetes (T1D) has been diagnosed late. By the time symptoms appear, the autoimmune destruction of pancreatic beta cells […]
The Daily Bolus The weekend news has produced a rare mix of genuinely interesting diabetes science alongside the usual commercial background noise. Notably, some of […]
For those in the “We Are Not Waiting” camp, the Sequel twiist pump was supposed to be the commercial homecoming for Tidepool Loop. It promised […]
The past 24 hours have continued to underscore the relentless pace of innovation within diabetes technology and research, presenting clinicians and individuals living […]
Date: January 13, 2026 If you’ve been following Diabettech for a while, you know that my focus has always been on the deep dives—the “Nine […]
Copyright © 2026 | WordPress Theme by MH Themes